Sultan Alharbi

Scientific Office and Regulatory Affairs Director at Pearl Therapeutics - Morristown, NJ, US

Sultan Alharbi's Colleagues at Pearl Therapeutics
Soraia Borba

Analista de Informações Médicas Sr

Contact Soraia Borba

Hossam Elgohary

Executive Medical Representative

Contact Hossam Elgohary

Aya Elkafrawy

Senior Respiratory Product Specialist

Contact Aya Elkafrawy

Anthony Fata

Manager, Non-Clinical Submissions

Contact Anthony Fata

Ann Stanley

Associate Director, Translational Scientific Management, Early Vaccines and Immune Therapies

Contact Ann Stanley

View All Sultan Alharbi's Colleagues
Sultan Alharbi's Contact Details
HQ
650-305-2600
Location
Saudi Arabia
Company
Pearl Therapeutics
Sultan Alharbi's Company Details
Pearl Therapeutics logo, Pearl Therapeutics contact details

Pearl Therapeutics

Morristown, NJ, US • 100 - 249 Employees
Major Drugs

AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines.Our Purpose is to push the boundaries of science to deliver life-changing medicines. We believe the best way we can achieve our Purpose is to put science at the centre of everything we do. Science defines who we are. It is why we come to work every day and is part of our DNA. But this is only half of the story. We know that we do not have all the answers. We want to share ideas because we believe it results in better medicines. We want the way we work to be inclusive, open and collaborative. This approach runs through all that we do.We focus on three main therapy areas – Oncology, Cardiovascular & Metabolic Disease (CVMD) and Respiratory – and we are also selectively active in the areas of autoimmunity, neuroscience and infection. To put ourselves in the best position to push the boundaries of science, we seek to leverage our combination of capabilities, which encompass both small molecules and biologics, and include immunotherapies and developing innovative delivery devices that can offer choice to patients. These are reinforced by a strong focus on personalised healthcare capabilities, which aim to match medicines only to those patients who will benefit from them. Our teams also work alongside the world's leading academic and biotech research institutions to stimulate innovation and evaluate emerging technologies such as Modified RNA and CRISPR genome editing.AstraZeneca operates in over 100 countries and its innovative medicines are used by millions of patients worldwide. For more information, visit www.astrazeneca.com.Community Guidelines: bit.ly/2MgAcio

Respiratory product development High quality therapies for COPD and Asthma B2B Major Drugs Pharmaceutical Preparations Pharmaceuticals
Details about Pearl Therapeutics
Frequently Asked Questions about Sultan Alharbi
Sultan Alharbi currently works for AstraZeneca.
Sultan Alharbi's role at AstraZeneca is Scientific Office and Regulatory Affairs Director.
Sultan Alharbi's email address is ***@astrazeneca.com. To view Sultan Alharbi's full email address, please signup to ConnectPlex.
Sultan Alharbi works in the Pharmaceuticals industry.
Sultan Alharbi's colleagues at Pearl Therapeutics are Nhat Do, Soraia Borba, Hossam Elgohary, Aya Elkafrawy, Anthony Fata, Federico Espinosa, Ann Stanley and others.
Sultan Alharbi's phone number is 650-305-2600
See more information about Sultan Alharbi